Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT

A. Kent, S. N. Ladhani, N. J. Andrews, T. Scorrer, A. J. Pollard, P. Clarke, S. M. Hughes, C. Heal, E. Menson, J. Chang, P. Satodia, A. C. Collinson, S. N. Faust, D. Goldblatt, E. Miller, P. T. Heath

Research output: Chapter in Book/Report/Conference proceedingChapter

21 Citations (Scopus)


BACKGROUND AND OBJECTIVE: Premature infants have a higher risk of invasive pneumococcal disease and are more likely to have lower vaccine responses compared with term infants. Increasingly, immunization schedules are including a reduced, 2-dose, pneumococcal conjugate vaccine priming schedule. Our goal was to assess the immunogenicity of 3 commonly used 13-valent pneumococcal conjugate vaccine (PCV13) priming schedules in premature infants and their response to a 12-month booster dose. METHODS: Premature infants (
Original languageEnglish
Title of host publicationPEDIATRICS
Publication statusPublished - 2016 Sept 1

Publication series



Dive into the research topics of 'Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT'. Together they form a unique fingerprint.

Cite this